Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled study of Kiacta in AA amyloidosis with renal involvement
2010-022313-25Phase 3Completed
- Sponsor
- A.T. Development
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in AA amyloidosis comparing Kiacta with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Oct 2010; status: completed.
02
Drugs
eprodisate
03
Conditions
AA amyloidosis
Beyond the preview
Go deeper on 2010-022313-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022313-25.